Ebola | |||||
NEWS | |||||
Merck ups outlook, turns profit during global vaccine hunt FAIRLESS HILLS, PA — Surging sales of its cancer medicines and reduced spending across the board helped Merck overcome a big hit from the ...
| |||||
Merck To Begin Studies Of Oral Coronavirus Treatment In September ... in its approved Ebola Zaire virus vaccine. The vaccine candidate is in preclinical development, with clinical studies planned to start later in the year.
| |||||
WEB | |||||
Why Is Covid-19 More Deadly Than Ebola? An Infectious Disease Doctor Explains The Zaire species of Ebola kills somewhere between 40% to 90% of its victims, and usually upwards of 60% of infected people die. Only a handful of ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar